Overview

Dr. Fernando Alberdi counsels public, private companies, and non-profit institutions such as hospitals, research institutions, and universities concerning the full spectrum of patent issues in the life sciences.

His practice involves designing and creating strategic solutions, leveraging complex intellectual property protection strategies for maximizing monetization and protection of clients’ intellectual property assets. Fernando assists clients in business-focused due diligence related to private and public financial transactions, licensing, and partnering opportunities.

With a doctorate degree and background in immunology and inflammation research, Fernando has experience in a broad range of technical areas, particularly within the life sciences, including immunology and immunotherapy, biologics/biosimilars, molecular biology including genomics, RNA and DNA interference technologies, molecular diagnostics, CRISPR, TALEN and Zinc Finger gene editing technologies, nucleic acid and peptide/protein therapeutics and diagnostics, recombinant protein expression, viral vectors, genetics, natural products, vaccines, drug delivery, and small molecule pharmaceuticals.

Fernando also advises companies in regard to third party intellectual property rights, drafting and prosecuting patents in a variety of technical areas, and assisting clients in a wide range of intellectual property matters. In particular, Fernando focuses on assessing patent landscapes, analyzing third-party patents, conducting periodic patent watches on competitor activity, and preparing freedom to operate, patentability, and invalidity opinions. 

Services

Industries

Experience

Representative Matters

  • U.S. Patent No. 8,795,783 Preparation of layer-by-layer materials and coatings from ionic liquids
  • U.S. Patent No. 8,794,175 Rolling contact layer-by-layer assembly
  • U.S. Patent No. 8,236,350 Polymer for tissue engineering applications and drug delivery
  • U.S. Patent No. 8,172,765 Method of assessment of airway variability in airway hyperresponsiveness
  • U.S. Patent No. 8,159,235 Electrical impedance tomography of nanoengineered thin films
  • U.S. Patent No. 8,057,390 High resolution mapping of bio-electric fields
  • U.S. Patent No. 8,053,514 Properties tailoring in silsesquioxanes
  • U.S. Patent No. 8,005,526 Biologically integrated electrode devices
  • U.S. Patent No. 7,917,302 Determination of optimal local sequence alignment similarity score
  • U.S. Patent No. 7,708,908 Carboxylic acid-modified EDOT for bioconjugation
  • U.S. Patent No. 7,704,716 Geraniol synthase, methods of production and uses thereof
  • U.S. Patent No. 7,696,406 Expression of a recombinant transgene
  • U.S. Patent No. 7,621,963 Composite bone graft material
  • U.S. Patent No. 7,611,853 Assay to screen for anti-malarials
  • U.S. Patent No. 7,509,240 Solid freeform fabrication of structurally engineered multifunctional devices
  • U.S. Patent No. 7,414,034 Treatment of Parkinson’s disease with oligonucleotides
  • U.S. Design Patent No. D667313 Pouch

Prior Experience

  • Harness, Dickey and Pierce P.L.C., Associate, 2005-2009
  • University of Michigan, Department of Microbiology, Post-Doctoral Research Fellow, 2000-2001
  • Oklahoma Medical Research Foundation, Senior Research Scientist, 1997–2000
  • University of Oklahoma, Post-Doctoral Research Fellow, 1995–1996
  • Royal Melbourne Institute of Technology, Research Scientist/Co-investigator, 1992-1995

Academic Appointments

  • University of Michigan, Intellectual Property and Patent Protection for Engineering Students, 2007-2008

Languages

  • Spanish

Credentials

Education

Admissions

Recognition

Awards

  • IAM Patent 1000: The World’s Leading Patent Professionals, Recognized as one of the World’s Leading Patent Practitioners, 2020-2021
  • Michigan Super Lawyers, Recognized as a Rising Star, 2013-2015

Professional & Community Involvement

American Bar Association

State Bar of Michigan

American Intellectual Property Law Association

Michigan Intellectual Property Law Association

News & Insights

News

  • Fernando Alberdi, Ph.D., mentioned in BusinessWire release “Biotechnology Patenting and Intellectual Property to be Highlighted at 2012 BIO International Convention” regarding his role as a speaker
    Media |

Publications

  • Cross reaction of mammalian Elongation Factor-2 to anti-double stranded DNA autoantibodies
    Publication | Clin. Immunol., 98(2):293-300 |
  • Antibodies to dsDNA cross react with Apolipoprotein A1
    Publication | Arthritis & Rheumatism, S:253 |
  • Expression and purification of recombinant CAP37 (rCAP37), a multifunctional inflammatory mediator
    Publication | Experimental Biology, FASEB J. 1997:11(3) | April 6-9, 1997
  • Discrimination of European and Australian Globodera rostochiensis and G. pallida pathotypes by high performance capillary electrophoresis
    Publication | Fundamental Applied Nematology, 20:187-193 |
  • Antibacterial peptides from porcine polymorphonuclear neutrophils
    Publication | Immunology and Cell Biology, 73(1):38-43 |
  • Characterization of Immunorelated peptides to Porcidin P1
    Publication | Immunology and Cell Biology, 73(6):505-510 |
  • Antimicrobial peptides from porcine neutrophils
    Publication | Journal of Leukocyte Biology, 73: S67 |
  • Antimicrobial peptides from porcine polymorphonuclear neutrophils
    Publication | Australian Microbiologist, 13: 157 |

Seminars & Events

  • Industry Liaison and Innovation: Drug Development Boot Camp
    Event | Halifax, Nova Scotia, CA | | | Presenter
  • Event | New York, NY | | | Presenter
  • Event | San Francisco, CA | | | Speaker
  • ED1 Implementation of the AIA, SBIR-STTR Reauthorization & JOBS Act: At the crossroads of US patenting, small business innovations & start-up laws & the impact on commercialization & tech transfer offices
    Event | San Antonio, TX | February 27-March 2, 2013 | | Speaker
  • America Invents Act Comes to Campus: The Impact on Commercialization and Technology Transfer Offices
    Event | Boston, MA | June 18-21, 2012 | Speaker
  • Gene patenting - Why do we care? Recent developments in Australia and the United States
    Event | Melbourne, Australia | | | Speaker
Jump to Page

By using this site, you agree to our Privacy Policy and our Disclaimer.